Evidence map›Paper›PMID 31917880›Full record

SynthesisPsychiatry and clinical neurosciences2020

Efficacy and safety of bright light therapy for manic and depressive symptoms in patients with bipolar disorder: A systematic review and meta-analysis.

Masahiro Takeshima, Tomohiro Utsumi, Yumi Aoki, Zhe Wang, Masahiro Suzuki, Isa Okajima, Norio Watanabe, Koichiro Watanabe, Yoshikazu Takaesu

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Psychiatry and clinical neurosciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Masahiro TakeshimaDepartment of Neuropsychiatry, Akita University Graduate School of Medicine, Akita, Japan.ORCID https://orcid.org/0000-0003-0614-7524
Tomohiro UtsumiDepartment of Psychiatry, Jikei University School of Medicine, Tokyo, Japan.
Yumi AokiPsychiatric & Mental Health Nursing, St. Luke's International University, Tokyo, Japan.ORCID https://orcid.org/0000-0002-2674-0707
Zhe WangRenaissance School of Medicine at Stony Brook University, New York, USA.
Masahiro SuzukiDepartment of Psychiatry, Nihon University School of Medicine, Tokyo, Japan.
Isa OkajimaDepartment of Psychological Counseling, Faculty of Humanities, Tokyo Kasei University, Tokyo, Japan.
Norio WatanabeDepartment of Health Promotion and Human Behavior and of Clinical Epidemiology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Koichiro WatanabeDepartment of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan.
Yoshikazu TakaesuDepartment of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0002-9169-3249

Funding

Japanese Ministry of Health, Labour and Welfare 19GC1012Japanese Ministry of Health, Labour and Welfare H29-Seishin-Ippan-001
6 · The paper itself

Abstract

aimThis systematic review and meta-analysis evaluated whether bright light therapy (BLT) is an effective and safe treatment for manic/depressive symptoms and a preventive measure for recurrent mood episodes in patients with bipolar disorder.

methodsA literature search of major electronic databases was conducted in June 2019, including all published articles up to that date. Two researchers independently selected relevant publications, extracted data, and evaluated methodological quality according to the Cochrane criteria.

resultsSix randomized controlled trials (RCT) evaluated the efficacy of BLT for bipolar depression. A meta-analysis found no significant differences between BLT and placebo for the following outcomes: (i) rates of remission from depressive episodes (risk ratio [RR]: 1.81, 95% confidence interval [CI]: 0.43 to 7.64, P = 0.42); (ii) depressive symptom scores (standardized mean difference: -0.25, 95%CI: -0.74 to 0.23, P = 0.30); and (iii) rates of manic switching (RR: 1.00, 95%CI: 0.28 to 3.59, P = 0.26). The sensitivity analysis for studies with low overall indirectness did show a significant antidepressant effect for BLT (RR: 3.09, 95%CI: 1.62 to 5.90, P = 0.006). No RCT investigated the effect of BLT in preventing the recurrence of mood episodes in the euthymic state or in improving manic symptoms in the manic state. No severe adverse events were reported.

conclusionWhile a meta-analysis was unable to demonstrate the efficacy of BLT for bipolar depression, a sensitivity analysis did show a significant effect. Further well-designed studies are needed to clarify the effectiveness of BLT, not only for the depressive state but also for other states, in the treatment of bipolar disorder.

Indexed as

PhototherapyBipolar DisorderDepressionHumansbipolar disorderbright light therapychronotherapydepressionphototherapy

Identifiers

PMID31917880
PMCPMC7187384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.